Evidence map›Paper›PMID 42245839›Full record

ArticleCureus2026

A Transparent, Simple, Audit-Oriented Python-Based Binary Allocation Prototype for Clinical Research.

Kevin T Malone

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kevin T MaloneEmergency Medicine, Baylor Scott & White Medical Center - Temple, Temple, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Clinical randomization requires more than approximate 1:1 allocation. It also requires sequence generation that is difficult to subvert, allocation concealment during enrollment, and an audit trail that can withstand retrospective review. Objective The primary objective of this proof-of-concept technical and methodological evaluation was to assess the inspectability and audit-oriented design of a lightweight Python-based two-arm allocation prototype. Secondary objectives were to characterize its short-run demonstration behavior and compare its transparency, traceability, and operational limitations with common clinical randomization workflows. Methods We performed a static review of the supplied Python source file and a retrospective review of the supplied allocation log. Log analysis included descriptive arm counts, exact binomial testing for 1:1 balance, an exploratory runs test, and lag-1 autocorrelation. The implementation was interpreted in light of the clinical-trial randomization and pseudorandom-number-generator literature. Results The current source code implements a lightweight two-arm allocation randomization prototype with features intended to support auditability and tamper-evident traceability. Each allocation advances a xorshift-inspired 64-bit generator, maps the resulting integer to arm 1 or 2, and records the underlying output and assignment arithmetic in a human-readable log. An example test log was run and contained 2,000 allocations, with 502 versus 498 assignments in the first 1,000 events and 1008 versus 992 assignments overall. The current source code also implements session seed capture and a chained SHA-256 digest intended to strengthen sequential traceability and show evidence of tampering. Conclusions The prototype's principal improvement over many ad hoc local workflows is operational transparency rather than proven statistical superiority. Its strongest contribution is a short, inspectable code path and an audit-oriented logging structure. Additional hardening would be required before use in concealment-sensitive or regulated trial settings.

Indexed as

auditrandomrandomizationresearchtransparent

Identifiers

PMID42245839
PMCPMC13231031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.